Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.
about
Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotypeIn vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular diseaseHaptoglobin genotype and its role in determining heme-iron mediated vascular diseaseThe haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavengingThe role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel diseasePharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.Effects of lead and mercury on the blood proteome of childrenCardiovascular complications of type 1 diabetes: update on the renal link.Pathophysiology of sleep apneaDetecting non-allelic homologous recombination from high-throughput sequencing data.Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.Evolution of the CD163 family and its relationship to the bovine gamma delta T cell co-receptor WC1.Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype.Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus.The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotypeHaptoglobin phenotype and abnormal uterine artery Doppler in a racially diverse cohort.The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.The genetics of vascular complications in diabetes mellitus.Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.Biomarker discovery in serum from patients with carotid atherosclerosisThe haptoglobin 1 allele correlates with white matter hyperintensities in middle-aged adults with type 1 diabetes.Plasma haptoglobin concentrations are elevated in patients with coronary artery disease.Haptoglobin genotype modulates the relationships of glycaemic control with cognitive function in elderly individuals with type 2 diabetesGenetic polymorphisms influence runners' responses to the dietary ingestion of antioxidant supplementation based on pequi oil (Caryocar brasiliense Camb.): a before-after study.Pleiotropic effects of intravascular haemolysis on vascular homeostasis.Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.Haptoglobin 2-2 genotype is associated with increased risk of type 2 diabetes mellitus in northern Chinese.Evaluation of haptoglobin genotypes in patients with metabolic syndrome: A preliminary report.The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype.Transcriptome analysis of the response to chronic constant hypoxia in zebrafish hearts.Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunctionThe Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetesGenetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study.Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?Haptoglobin genotype and its role in diabetic cardiovascular disease.
P2860
Q24634553-82BB8567-0BFC-44C5-80CB-386C1A872CA9Q24681371-7EB98571-2124-4C15-B170-0677CDDE87FBQ26852155-F92FD964-664A-4078-8078-0D1EEE2B18FCQ26864505-DCF44790-0CE9-46AB-AA33-10C26D03EEA9Q27007776-7F63043A-4CDD-45E5-8F6A-4253E267CCACQ27332892-4D9B83FE-DECF-40EF-BB7D-FC03190ACC2EQ28383202-6E481DE2-0E1A-4472-9ECC-098E24E2D7F0Q30239971-A096BACF-F124-4A23-94C6-31C0F74A2F8EQ30440658-349B003D-83BF-4C7F-B6A7-AC42DBED7565Q30935536-BF5ACFAA-78D5-45E9-980B-0187DC0953A4Q33395871-6094A667-3F17-4486-9CC3-F7D7008D604EQ33605328-CE63482B-847C-4208-AFD6-F00E3338493BQ33649886-E3053734-9691-4224-83CE-AE8A9D956879Q33659216-6CBB94FE-B19E-483A-8917-9B6A41422142Q33695531-55DD0CE8-19AD-4A20-BA0E-C9858FF73950Q33718536-0D4FB4F2-2A44-45BD-9A3B-C9E93CBAC612Q33805731-CD65C81B-F93A-4620-B186-3D7434E9C765Q33894052-BF0778A7-CD68-48DD-9768-942FEF83B7E9Q33896045-5845C5AD-BC2E-426B-8AF2-859030902DDEQ33965252-DAD2384B-7F21-48D2-9310-A1E6118CC4E2Q33995879-A9CD42FC-0C63-4CA9-9C67-887FE7E1D536Q34023548-83502336-7454-49DC-B29D-D1E67DCB284EQ34051581-6935ADD7-F8EF-4F77-B6CC-53E495AEF499Q34261476-0E2ADD93-0073-41A7-9265-56D7953DD04DQ35004339-4C52FA4C-F3E1-40A8-8447-07660D71E82FQ35018577-2573F35E-A498-43EA-B396-2165EC597788Q35155827-7CEAE225-9C55-499B-B2B7-3885F1B3ABE8Q35401476-8BDE1CA3-4CD5-4773-AE30-3A18D102B085Q35535204-8B09A819-7024-4C3A-9BD9-CF75C8F655FCQ35596083-47422B36-6299-4749-86F8-DB11E4DFDC64Q35744436-8379510B-E45A-4360-A51D-6C4C935300A3Q36041704-5C759B7D-EDA7-47E3-A522-BB7F217F91C0Q36055337-19E86B9C-9B4C-4B0B-B179-CB97532CFFA9Q36193251-8CCDCDA6-AC39-47F2-8173-63E61A6F49A9Q36384133-D13F53F1-2E18-4BC6-9284-69120CC7C733Q36441429-AE59B40D-E9EC-4E50-98C2-F7AC6FB319D1Q36600400-2D439D98-777A-473A-A87A-33140E9FFD17Q36621400-9ACE2345-1C05-4FFB-87F8-4310EE5CC661Q36664118-C475269D-6C50-45D1-9345-963B7C769AB4Q36678611-434E5B1D-B849-40B2-994D-D6159204253C
P2860
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Haptoglobin phenotype is an in ...... betes: The Strong Heart Study.
@en
Haptoglobin phenotype is an in ...... betes: The Strong Heart Study.
@nl
type
label
Haptoglobin phenotype is an in ...... betes: The Strong Heart Study.
@en
Haptoglobin phenotype is an in ...... betes: The Strong Heart Study.
@nl
prefLabel
Haptoglobin phenotype is an in ...... betes: The Strong Heart Study.
@en
Haptoglobin phenotype is an in ...... betes: The Strong Heart Study.
@nl
P2093
P50
P1476
Haptoglobin phenotype is an in ...... betes: The Strong Heart Study.
@en
P2093
Andrew P Levy
Helaine E Resnick
Irit Hochberg
Kathleen Jablonski
Strong Heart Study
P304
P356
10.1016/S0735-1097(02)02534-2
P407
P577
2002-12-01T00:00:00Z